Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering RNAs

Details for Australian Patent Application No. 2011203218 (hide)

Owner Hartmann, G. Hornung, V. Endres, S. Alnylam Pharmaceuticals, Inc.

Inventors Hartmann, Gunther; Hornung, Veit; Endres, Stefan; De Fougerolles, Antonin

Agent Griffith Hack

Pub. Number AU-A-2011203218

Parent 2005313883

Filing date 30 June 2011

Wipo publication date 21 July 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

21 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203218

21 July 2011 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203219-Mode removal for improved multi-modal background subtraction

2011203217-Dipeptidyl peptidase inhibitors